Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Kornek

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 22, 2025
Diagnostic accuracy of inter-eye difference of ganglion cell layer alone in identifying optic neuritis in multiple sclerosisNik Krajnc, Fabian Föttinger, Markus Ponleitner, et al.
Journal of Neurology|April 19, 2023
Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)Tobias Monschein, Sarinah Dekany, Tobias Zrzavy, et al.
Journal of Neurology|November 19, 2025
Safety of disease-modifying therapies in multiple sclerosis: real-world data from the Austrian MS Treatment Registry (AMSTR)Tobias Monschein, Helena Untersteiner, Markus Ponleitner, et al.
Brain Communications|November 12, 2025
Dynamic relationship between cerebrospinal fluid immune cells and tissue damage markers in multiple sclerosisSina Zaic, Theresa König, Markus Ponleitner, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 20, 2025
Serum neurofilament light chain and glial fibrillary acidic protein levels are associated with inner retinal layer thinning in multiple sclerosisNik Krajnc, Markus Ponleitner, Fabian Föttinger, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|September 10, 2018
Clinical and magnetic resonance imaging features of children, adolescents, and adults with a clinically isolated syndromeRuxandra-Iulia Milos, Martin Szimacsek, Fritz Leutmezer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 13, 2016
Children with multiphasic disseminated encephalomyelitis and antibodies to the myelin oligodendrocyte glycoprotein (MOG): Extending the spectrum of MOG antibody positive diseasesMatthias Baumann, Eva-Maria Hennes, Kathrin Schanda, et al.
Frontiers in Neurology|May 1, 2024
Immunophenotyping in routine clinical practice for predicting treatment response and adverse events in patients with MSTobias Zrzavy, Kerstin Rieder, Viktoria Wuketich, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 20, 2020
Rituximab in patients with pediatric multiple sclerosis and other demyelinating disorders of the CNS: Practical considerationsAngelo Ghezzi, Brenda Banwell, Amit Bar-Or, et al.
Neurology|July 3, 2023
Diagnostic Performance of Adding the Optic Nerve Region Assessed by Optical Coherence Tomography to the Diagnostic Criteria for Multiple SclerosisGabriel Bsteh, Harald Hegen, Patrick Altmann, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 22, 2025
Diagnostic accuracy of inter-eye difference of ganglion cell layer alone in identifying optic neuritis in multiple sclerosisNik Krajnc, Fabian Föttinger, Markus Ponleitner, et al.
Journal of Neurology|April 19, 2023
Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)Tobias Monschein, Sarinah Dekany, Tobias Zrzavy, et al.
Journal of Neurology|November 19, 2025
Safety of disease-modifying therapies in multiple sclerosis: real-world data from the Austrian MS Treatment Registry (AMSTR)Tobias Monschein, Helena Untersteiner, Markus Ponleitner, et al.
Brain Communications|November 12, 2025
Dynamic relationship between cerebrospinal fluid immune cells and tissue damage markers in multiple sclerosisSina Zaic, Theresa König, Markus Ponleitner, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 20, 2025
Serum neurofilament light chain and glial fibrillary acidic protein levels are associated with inner retinal layer thinning in multiple sclerosisNik Krajnc, Markus Ponleitner, Fabian Föttinger, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|September 10, 2018
Clinical and magnetic resonance imaging features of children, adolescents, and adults with a clinically isolated syndromeRuxandra-Iulia Milos, Martin Szimacsek, Fritz Leutmezer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 13, 2016
Children with multiphasic disseminated encephalomyelitis and antibodies to the myelin oligodendrocyte glycoprotein (MOG): Extending the spectrum of MOG antibody positive diseasesMatthias Baumann, Eva-Maria Hennes, Kathrin Schanda, et al.
Frontiers in Neurology|May 1, 2024
Immunophenotyping in routine clinical practice for predicting treatment response and adverse events in patients with MSTobias Zrzavy, Kerstin Rieder, Viktoria Wuketich, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 20, 2020
Rituximab in patients with pediatric multiple sclerosis and other demyelinating disorders of the CNS: Practical considerationsAngelo Ghezzi, Brenda Banwell, Amit Bar-Or, et al.
Neurology|July 3, 2023
Diagnostic Performance of Adding the Optic Nerve Region Assessed by Optical Coherence Tomography to the Diagnostic Criteria for Multiple SclerosisGabriel Bsteh, Harald Hegen, Patrick Altmann, et al.
Pageof 7